Hair loss can be traumatic and, unfortunately, extremely common. But a New Jersey doctor says he has a new treatment.
Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback